Phase 1 Dose-escalation PK/PD Trial in Advanced Cancer Patients

NCT00610194 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
69
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Bayer